Rise in global geriatric population, surge in prevalence of cardiovascular diseases, increase in investments in R&D activities, and advent of innovative minimally invasive heart valve repair procedures are driving the heart valve devices market growth.
Heart valve devices are used for the treatment of valvular disorders, caused by factors such as old age, calcification on heart valves, and sometimes, due to rheumatic fever. Implantation of heart valve devices is one of the most common treatment procedures for rectification of structural heart problems.
Biological surgical valves, transcatheter heart valves, and mechanical valves are the different types of structural heart valve equipment available in the market.
Surge in collaborations and partnerships between healthcare entities and research institutions, aimed at improving heart valve device research and mitigate associated risk factors, contributes significantly to heart valve devices market expansion.
Heart valves that are diseased or damaged are replaced with heart valve devices. These devices guarantee that blood flows in the proper direction throughout each heartbeat and prevents blood from flowing backward. Ideally, a replacement heart valve should offer long-term durability without increasing the chances of clotting disorders.
One of the major types of heart valve devices used for treatment of structural heart disorders include aortic valves. Aortic heart valve devices are used to treat aortic stenosis, a condition where the aortic valve becomes narrowed, restricting blood flow from the heart. Aortic heart valve devices are primarily of two types, transcatheter aortic valve implantation (TAVI) and surgical aortic valves.
Several companies are engaged in providing heart valve devices for the repair or replacement of diseased or damaged heart valves. These devices are essential for improving overall cardiac health and quality of life of patients with severe valvular disorders.
Over the last decade, adoption of transcatheter aortic valve implantation (TAVI) has increased remarkably due to improved safety and efficacy of these procedures. Further, the approval of TAVI for treatment of low risk patients has significantly increased its adoption. Other advantages of the procedure include faster recovery and less invasive nature of the intervention.
| Attribute | Detail |
|---|---|
| Drivers |
|
Two recent scientific studies suggest that in an older and more diverse U.S. population, cardiovascular disease may affect at least 6 out of 10 people within the next 30 years.
Additionally, according to these forecasts, the percentage of Americans who have high blood pressure is likely to increase from 51.2% to 61% between 2020 and 2050.
Obesity rates are expected to increase from 43.1% to 60.6% of the population as a result of bad diets and sedentary lifestyles, with people aged 20 to 64 probably experiencing the greatest expansion. By 2050, the estimated rise in heart disease and stroke is expected to result in a US$ 1.8 trillion financial burden.
Further, the British Heart Foundation estimates that 7.6 million people in the United Kingdom suffer from cardiovascular diseases.
Congenital heart defects and diseases that arise during life, such as coronary heart disease, atrial fibrillation, heart failure, stroke, and vascular dementia, are among these conditions.
It is estimated that 3.6 million women and 4 million men experience these diseases. Thus, the surge in incidence of cardiovascular disorders is poised to bolster the heart valve devices market growth.
The American Hospital Association urges the government administration to prioritize funding for America’s hospital infrastructure. These investments are critical to ensure the overall health and security of the nation, the long-term sustainability and viability of hospitals, and the wellbeing of patients and communities.
It is necessary to invest in hospital physical infrastructure, strengthening the healthcare workforce, expand capacity for emergency preparedness and response, improve the digital and data infrastructure for healthcare, and secure the healthcare supply chain.
Further, the importance of capital investments in medical equipment and health infrastructure has grown throughout Europe. Information technology and diagnostic tools are two important factors in the creation of health services.
The EU invested over EUR 8 billion in health-related projects between 2014 and 2018. These projects focus on health promotion, education, system reform, and research and innovation.
The heart valve devices market segmentation based on type of heart valve includes aortic valve, mitral valve, tricuspid valve, and pulmonary valve.
Aortic valves currently hold a significant share in the overall market. The aortic valve segment accounts for largest heart valve devices market revenue share owing to increase in prevalence of aortic stenosis.
Further, treatment options for aortic valve disorders is increasing with the advent of minimally invasive technologies. The high cost of such next generation treatment approaches is a major factor driving the growth of the segment.
According to the heart valve devices industry report, based on material, the market is classified into biological valves, and mechanical valves. The biological valves segment dominates the heart valve devices market.
A paradigm shift to the use of tissue valve (made of bovine or porcine pericardium tissue) from traditional mechanical valves is exerting a positive influence on the segment.
Further, biological valves closely mimic the function and form of human heart valves. Additionally, these valves are treated with chemicals to delay calcification and stiffening in order to prolong their lifespan.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
According to the latest heart valve devices market analysis, North America held dominant share in 2023. Advancement of healthcare infrastructure, high investments in research, and augmented healthcare finances are driving market dynamics in the region.
In the U.S., several companies are launching innovative heart valve device solutions to strengthen their market position. For instance, in April 2024, Abbott announced that it received U.S. FDA approval for first-of-its-kind TriClip transcatheter edge-to-edge repair (TEER) system, specifically designed for the treatment of tricuspid regurgitation or leaky tricuspid valve.
Several global heart valve device providers are based in Europe where considerable growth in market share of the aortic valve segment is anticipated during the forecast period.
Over the years, there has been a notable increase in the proportion of older adults in the Asia Pacific region, rising from 4% to 10% between 1970 and 2023, and projected to reach 19% by 2050.
Expansion of the heart valve devices market share in Asia Pacific at the highest CAGR is ascribed to the surge in demand for novel therapeutic approaches.
Furthermore, the heart valve devices market value in the region is anticipated to rise due to increase in instrument commercialization, rise in adoption of transcatheter aortic valve implantation approaches, and entry of multinational firms within the marketplace.
As heart valve device providers are constantly innovating to improve product capabilities, innovative devices are being introduced for better workflow efficiency.
Medtronic plc, Boston Scientific Corporation, Abbott, Edwards Lifesciences Corporation, Foldax Inc., Novostia SA, Meril Life Sciences Pvt. Ltd., Corcym UK Limited, JenaValve Technology, Inc., Micro Interventional Devices, Inc., Auto Tissue Berlin GmbH, Anteris Technologies Ltd, Thubrikar Aortic Valve, Inc., MicroPort Scientific Corporation, and Biosensors International Group, Ltd. are the prominent heart valve devices market players.
Each of these players has been profiled in the heart valve devices market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Size in 2023 | US$ 10.9 Bn |
| Forecast Value in 2034 | More than US$ 38.2 Bn |
| CAGR | 11.7% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2023 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 10.9 Bn in 2023
It is projected to reach more than US$ 38.2 Bn by the end of 2034
The CAGR is anticipated to be 11.7% from 2024 to 2034
Medtronic plc, Boston Scientific Corporation, Abbott, Edwards Lifesciences Corporation, Foldax Inc., Novostia SA, Meril Life Sciences Pvt. Ltd., Corcym UK Limited, JenaValve Technology, Inc., Micro Interventional Devices, Inc., Auto Tissue Berlin GmbH, Anteris Technologies Ltd, Thubrikar Aortic Valve, Inc., MicroPort Scientific Corporation, and Biosensors International Group, Ltd.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Heart Valve Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Heart Valve Devices Market Analysis and Forecasts, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Insights on Global Burden of Cardiovascular Diseases
5.2. Regulatory Landscape for Heart Valve Devices in Key Regions / Countries
5.3. Overview on Cardiovascular Surgical Procedures
5.4. Key Industry Events (Product Approvals, Partnerships, and Collaborations)
5.5. Technological Advancements in the Field of Heart Valve Surgeries
5.6. Reimbursement Scenario across Key Regions / Countries
5.7. Pricing Trends of Heart Valve Devices
5.8. PEST Analysis
5.9. Key Product / Brand Analysis
5.10. Insights on Global Burden of Cardiovascular Diseases
6. Global Heart Valve Devices Market Analysis and Forecasts, By Type of Heart Valve
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Type of Heart Valve, 2020-2034
6.3.1. Aortic Valve
6.3.1.1. Less than 20 mm
6.3.1.2. 20-23 mm
6.3.1.3. 23-26 mm
6.3.1.4. More than 26 mm
6.3.2. Mitral Valve
6.3.2.1. Less than 26 mm
6.3.2.2. 26-28 mm
6.3.2.3. 29-31 mm
6.3.2.4. More than 31 mm
6.3.3. Tricuspid Valve
6.3.4. Pulmonary Valve
6.4. Market Attractiveness By Type of Heart Valve
7. Global Heart Valve Devices Market Analysis and Forecasts, By Material
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Material, 2020-2034
7.3.1. Biological Valves
7.3.1.1. TAVI
7.3.1.2. Surgical
7.3.1.3. Others
7.3.2. Mechanical Valves
7.4. Market Attractiveness By Material
8. Global Heart Valve Devices Market Analysis and Forecasts, By Age Group
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Age Group, 2020-2034
8.3.1. Pediatric Patients
8.3.2. Adults
8.3.3. Geriatric Patients
8.4. Market Attractiveness By Age Group
9. Global Heart Valve Devices Market Analysis and Forecasts, By End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By End-user, 2020-2034
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Others
9.4. Market Attractiveness By End-user
10. Global Heart Valve Devices Market Analysis and Forecasts, By Region
10.1. Key Findings
10.2. Market Value Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Region
11. North America Heart Valve Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Type of Heart Valve, 2020-2034
11.2.1. Aortic Valve
11.2.1.1. Less than 20 mm
11.2.1.2. 20-23 mm
11.2.1.3. 23-26 mm
11.2.1.4. More than 26 mm
11.2.2. Mitral Valve
11.2.2.1. Less than 26 mm
11.2.2.2. 26-28 mm
11.2.2.3. 29-31 mm
11.2.2.4. More than 31 mm
11.2.3. Tricuspid Valve
11.2.4. Pulmonary Valve
11.3. Market Value Forecast By Material, 2020-2034
11.3.1. Biological Valves
11.3.1.1. TAVI
11.3.1.2. Surgical
11.3.1.3. Others
11.3.2. Mechanical Valves
11.4. Market Value Forecast By Age Group, 2020-2034
11.4.1. Pediatric Patients
11.4.2. Adults
11.4.3. Geriatric Patients
11.5. Market Value Forecast By End-user, 2020-2034
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Others
11.6. Market Value Forecast By Country, 2020-2034
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Type of Heart Valve
11.7.2. By Material
11.7.3. By Age Group
11.7.4. By End-user
11.7.5. By Country
12. Europe Heart Valve Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Type of Heart Valve, 2020-2034
12.2.1. Aortic Valve
12.2.1.1. Less than 20 mm
12.2.1.2. 20-23 mm
12.2.1.3. 23-26 mm
12.2.1.4. More than 26 mm
12.2.2. Mitral Valve
12.2.2.1. Less than 26 mm
12.2.2.2. 26-28 mm
12.2.2.3. 29-31 mm
12.2.2.4. More than 31 mm
12.2.3. Tricuspid Valve
12.2.4. Pulmonary Valve
12.3. Market Value Forecast By Material, 2020-2034
12.3.1. Biological Valves
12.3.1.1. TAVI
12.3.1.2. Surgical
12.3.1.3. Others
12.3.2. Mechanical Valves
12.4. Market Value Forecast By Age Group, 2020-2034
12.4.1. Pediatric Patients
12.4.2. Adults
12.4.3. Geriatric Patients
12.5. Market Value Forecast By End-user, 2020-2034
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Others
12.6. Market Value Forecast By Country / Sub-region, 2020-2034
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Type of Heart Valve
12.7.2. By Material
12.7.3. By Age Group
12.7.4. By End-user
12.7.5. By Country / Sub-region
13. Asia Pacific Heart Valve Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Type of Heart Valve, 2020-2034
13.2.1. Aortic Valve
13.2.1.1. Less than 20 mm
13.2.1.2. 20-23 mm
13.2.1.3. 23-26 mm
13.2.1.4. More than 26 mm
13.2.2. Mitral Valve
13.2.2.1. Less than 26 mm
13.2.2.2. 26-28 mm
13.2.2.3. 29-31 mm
13.2.2.4. More than 31 mm
13.2.3. Tricuspid Valve
13.2.4. Pulmonary Valve
13.3. Market Value Forecast By Material, 2020-2034
13.3.1. Biological Valves
13.3.1.1. TAVI
13.3.1.2. Surgical
13.3.1.3. Others
13.3.2. Mechanical Valves
13.4. Market Value Forecast By Age Group, 2020-2034
13.4.1. Pediatric Patients
13.4.2. Adults
13.4.3. Geriatric Patients
13.5. Market Value Forecast By End-user, 2020-2034
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Others
13.6. Market Value Forecast By Country / Sub-region, 2020-2034
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Type of Heart Valve
13.7.2. By Material
13.7.3. By Age Group
13.7.4. By End-user
13.7.5. By Country / Sub-region
14. Latin America Heart Valve Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Type of Heart Valve, 2020-2034
14.2.1. Aortic Valve
14.2.1.1. Less than 20 mm
14.2.1.2. 20-23 mm
14.2.1.3. 23-26 mm
14.2.1.4. More than 26 mm
14.2.2. Mitral Valve
14.2.2.1. Less than 26 mm
14.2.2.2. 26-28 mm
14.2.2.3. 29-31 mm
14.2.2.4. More than 31 mm
14.2.3. Tricuspid Valve
14.2.4. Pulmonary Valve
14.3. Market Value Forecast By Material, 2020-2034
14.3.1. Biological Valves
14.3.1.1. TAVI
14.3.1.2. Surgical
14.3.1.3. Others
14.3.2. Mechanical Valves
14.4. Market Value Forecast By Age Group, 2020-2034
14.4.1. Pediatric Patients
14.4.2. Adults
14.4.3. Geriatric Patients
14.5. Market Value Forecast By End-user, 2020-2034
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers
14.5.3. Others
14.6. Market Value Forecast By Country / Sub-region, 2020-2034
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Type of Heart Valve
14.7.2. By Material
14.7.3. By Age Group
14.7.4. By End-user
14.7.5. By Country / Sub-region
15. Middle East & Africa Heart Valve Devices Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Type of Heart Valve, 2020-2034
15.2.1. Aortic Valve
15.2.1.1. Less than 20 mm
15.2.1.2. 20-23 mm
15.2.1.3. 23-26 mm
15.2.1.4. More than 26 mm
15.2.2. Mitral Valve
15.2.2.1. Less than 26 mm
15.2.2.2. 26-28 mm
15.2.2.3. 29-31 mm
15.2.2.4. More than 31 mm
15.2.3. Tricuspid Valve
15.2.4. Pulmonary Valve
15.3. Market Value Forecast By Material, 2020-2034
15.3.1. Biological Valves
15.3.1.1. TAVI
15.3.1.2. Surgical
15.3.1.3. Others
15.3.2. Mechanical Valves
15.4. Market Value Forecast By Age Group, 2020-2034
15.4.1. Pediatric Patients
15.4.2. Adults
15.4.3. Geriatric Patients
15.5. Market Value Forecast By End-user, 2020-2034
15.5.1. Hospitals
15.5.2. Ambulatory Surgical Centers
15.5.3. Others
15.6. Market Value Forecast By Country / Sub-region, 2020-2034
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Type of Heart Valve
15.7.2. By Material
15.7.3. By Age Group
15.7.4. By End-user
15.7.5. By Country / Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Company Profiles
16.2.1. Medtronic plc
16.2.1.1. Company Overview
16.2.1.2. Financial Overview
16.2.1.3. Product Portfolio
16.2.1.4. Business Strategies
16.2.1.5. Recent Developments
16.2.2. Boston Scientific Corporation
16.2.2.1. Company Overview
16.2.2.2. Financial Overview
16.2.2.3. Product Portfolio
16.2.2.4. Business Strategies
16.2.2.5. Recent Developments
16.2.3. Abbott
16.2.3.1. Company Overview
16.2.3.2. Financial Overview
16.2.3.3. Product Portfolio
16.2.3.4. Business Strategies
16.2.3.5. Recent Developments
16.2.4. Edwards Lifesciences Corporation
16.2.4.1. Company Overview
16.2.4.2. Financial Overview
16.2.4.3. Product Portfolio
16.2.4.4. Business Strategies
16.2.4.5. Recent Developments
16.2.5. Foldax Inc.
16.2.5.1. Company Overview
16.2.5.2. Financial Overview
16.2.5.3. Product Portfolio
16.2.5.4. Business Strategies
16.2.5.5. Recent Developments
16.2.6. Novostia SA
16.2.6.1. Company Overview
16.2.6.2. Financial Overview
16.2.6.3. Product Portfolio
16.2.6.4. Business Strategies
16.2.6.5. Recent Developments
16.2.7. Meril Life Sciences Pvt. Ltd.
16.2.7.1. Company Overview
16.2.7.2. Financial Overview
16.2.7.3. Product Portfolio
16.2.7.4. Business Strategies
16.2.7.5. Recent Developments
16.2.8. Corcym UK Limited
16.2.8.1. Company Overview
16.2.8.2. Financial Overview
16.2.8.3. Product Portfolio
16.2.8.4. Business Strategies
16.2.8.5. Recent Developments
16.2.9. JenaValve Technology, Inc.
16.2.9.1. Company Overview
16.2.9.2. Financial Overview
16.2.9.3. Product Portfolio
16.2.9.4. Business Strategies
16.2.9.5. Recent Developments
16.2.10. Micro Interventional Devices, Inc.
16.2.10.1. Company Overview
16.2.10.2. Financial Overview
16.2.10.3. Product Portfolio
16.2.10.4. Business Strategies
16.2.10.5. Recent Developments
16.2.11. Auto Tissue Berlin GmbH
16.2.11.1. Company Overview
16.2.11.2. Financial Overview
16.2.11.3. Product Portfolio
16.2.11.4. Business Strategies
16.2.11.5. Recent Developments
16.2.12. Anteris Technologies Ltd
16.2.12.1. Company Overview
16.2.12.2. Financial Overview
16.2.12.3. Product Portfolio
16.2.12.4. Business Strategies
16.2.12.5. Recent Developments
16.2.13. Thubrikar Aortic Valve, Inc.
16.2.13.1. Company Overview
16.2.13.2. Financial Overview
16.2.13.3. Product Portfolio
16.2.13.4. Business Strategies
16.2.13.5. Recent Developments
16.2.14. MicroPort Scientific Corporation
16.2.14.1. Company Overview
16.2.14.2. Financial Overview
16.2.14.3. Product Portfolio
16.2.14.4. Business Strategies
16.2.14.5. Recent Developments
16.2.15. Biosensors International Group, Ltd.
16.2.15.1. Company Overview
16.2.15.2. Financial Overview
16.2.15.3. Product Portfolio
16.2.15.4. Business Strategies
16.2.15.5. Recent Developments
List of Tables
Table 1: Global Heart Valve Devices Market Value (US$ Mn) Forecast, by Type of Heart Valve, 2020-2034
Table 2: Global Heart Valve Devices Market Value (US$ Mn) Forecast, by Aortic Valve, 2020-2034
Table 3: Global Heart Valve Devices Market Value (US$ Mn) Forecast, by Mitral Valve, 2020-2034
Table 4: Global Heart Valve Devices Market Value (US$ Mn) Forecast, by Material, 2020-2034
Table 5: Global Heart Valve Devices Market Value (US$ Mn) Forecast, by Biological Valves, 2020-2034
Table 6: Global Heart Valve Devices Market Value (US$ Mn) Forecast, by Age Group, 2020-2034
Table 7: Global Heart Valve Devices Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 8: Global Heart Valve Devices Market Value (US$ Mn) Forecast, by Region, 2020-2034
Table 9: North America Heart Valve Devices Market Value (US$ Mn) Forecast, by Country, 2020-2034
Table 10: North America Heart Valve Devices Market Value (US$ Mn) Forecast, by Type of Heart Valve, 2020-2034
Table 11: North America Heart Valve Devices Market Value (US$ Mn) Forecast, by Aortic Valve, 2020-2034
Table 12: North America Heart Valve Devices Market Value (US$ Mn) Forecast, by Mitral Valve, 2020-2034
Table 13: North America Heart Valve Devices Market Value (US$ Mn) Forecast, by Material, 2020-2034
Table 14: North America Heart Valve Devices Market Value (US$ Mn) Forecast, by Biological Valves, 2020-2034
Table 15: North America Heart Valve Devices Market Value (US$ Mn) Forecast, by Age Group, 2020-2034
Table 16: North America Heart Valve Devices Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 17: Europe Heart Valve Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Europe Heart Valve Devices Market Value (US$ Mn) Forecast, by Type of Heart Valve, 2020-2034
Table 19: Europe Heart Valve Devices Market Value (US$ Mn) Forecast, by Aortic Valve, 2020-2034
Table 20: Europe Heart Valve Devices Market Value (US$ Mn) Forecast, by Mitral Valve, 2020-2034
Table 21: Europe Heart Valve Devices Market Value (US$ Mn) Forecast, by Material, 2020-2034
Table 22: Europe Heart Valve Devices Market Value (US$ Mn) Forecast, by Biological Valves, 2020-2034
Table 23: Europe Heart Valve Devices Market Value (US$ Mn) Forecast, by Age Group, 2020-2034
Table 24: Europe Heart Valve Devices Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 25: Asia Pacific Heart Valve Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 26: Asia Pacific Heart Valve Devices Market Value (US$ Mn) Forecast, by Type of Heart Valve, 2020-2034
Table 27: Asia Pacific Heart Valve Devices Market Value (US$ Mn) Forecast, by Aortic Valves, 2020-2034
Table 28: Asia Pacific Heart Valve Devices Market Value (US$ Mn) Forecast, by Mitral Valve, 2020-2034
Table 29: Asia Pacific Heart Valve Devices Market Value (US$ Mn) Forecast, by Material, 2020-2034
Table 30: Asia Pacific Heart Valve Devices Market Value (US$ Mn) Forecast, by Biological Valves, 2020-2034
Table 31: Asia Pacific Heart Valve Devices Market Value (US$ Mn) Forecast, by Age Group, 2020-2034
Table 32: Asia Pacific Heart Valve Devices Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 33: Latin America Heart Valve Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 34: Latin America Heart Valve Devices Market Value (US$ Mn) Forecast, by Type of Heart Valve, 2020-2034
Table 35: Latin America Heart Valve Devices Market Value (US$ Mn) Forecast, by Aortic Valve, 2020-2034
Table 36: Latin America Heart Valve Devices Market Value (US$ Mn) Forecast, by Mitral Valve, 2020-2034
Table 37: Latin America Heart Valve Devices Market Value (US$ Mn) Forecast, by Material, 2020-2034
Table 38: Latin America Heart Valve Devices Market Value (US$ Mn) Forecast, by Biological Valves, 2020-2034
Table 39: Latin America Heart Valve Devices Market Value (US$ Mn) Forecast, by Age Group, 2020-2034
Table 40: Latin America Heart Valve Devices Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 41: Middle East & Africa Heart Valve Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 42: Middle East & Africa Heart Valve Devices Market Value (US$ Mn) Forecast, by Type of Heart Valve, 2020-2034
Table 43: Middle East & Africa Heart Valve Devices Market Value (US$ Mn) Forecast, by Aortic Valve, 2020-2034
Table 44: Middle East & Africa Heart Valve Devices Market Value (US$ Mn) Forecast, by Mitral Valve, 2020-2034
Table 45: Middle East & Africa Heart Valve Devices Market Value (US$ Mn) Forecast, by Material, 2020-2034
Table 46: Middle East & Africa Heart Valve Devices Market Value (US$ Mn) Forecast, by Biological Valves, 2020-2034
Table 47: Middle East & Africa Heart Valve Devices Market Value (US$ Mn) Forecast, by Age Group, 2020-2034
Table 48: Middle East & Africa Heart Valve Devices Market Value (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 1: Global Heart Valve Devices Market Value (US$ Mn) Forecast, 2020-2034
Figure 2: Global Heart Valve Devices Market Value Share, by Type of Heart Valve, 2023
Figure 3: Global Heart Valve Devices Market Value Share, by Material, 2023
Figure 4: Global Heart Valve Devices Market Value Share, by Age Group, 2023
Figure 5: Global Heart Valve Devices Market Value Share, by End-user, 2023
Figure 6: Global Heart Valve Devices Market Value Share, by Region, 2023
Figure 7: Global Heart Valve Devices Market Value (US$ Mn) Share Analysis, by Type of Heart Valve, 2023 and 2034
Figure 8: Global Heart Valve Devices Market Share Analysis, by Type of Heart Valve, 2023
Figure 9: Global Heart Valve Devices Market Share Analysis, by Type of Heart Valve, 2034
Figure 10: Global Heart Valve Devices Market Attractiveness Analysis, by Type of Heart Valve, 2024-2034
Figure 11: Global Heart Valve Devices Market Value (US$ Mn), by Aortic Valve, 2020-2034
Figure 12: Global Heart Valve Devices Market Value Share Analysis, by Aortic Valve, 2023 and 2034
Figure 13: Global Heart Valve Devices Market Value (US$ Mn), by Mitral Valve, 2020-2034
Figure 14: Global Heart Valve Devices Market Value Share Analysis, by Mitral Valve, 2023 and 2034
Figure 15: Global Heart Valve Devices Market Value (US$ Mn), by Tricuspid Valve, 2020-2034
Figure 16: Global Heart Valve Devices Market Value Share Analysis, by Tricuspid Valve, 2023 and 2034
Figure 17: Global Heart Valve Devices Market Value (US$ Mn), by Pulmonary Valve, 2020-2034
Figure 18: Global Heart Valve Devices Market Value Share Analysis, by Pulmonary Valve, 2023 and 2034
Figure 19: Global Heart Valve Devices Market Value (US$ Mn) Share Analysis, by Material, 2023 and 2034
Figure 20: Global Heart Valve Devices Market Share Analysis, by Material, 2023
Figure 21: Global Heart Valve Devices Market Share Analysis, by Material, 2034
Figure 22: Global Heart Valve Devices Market Attractiveness Analysis, by Material, 2024-2034
Figure 23: Global Heart Valve Devices Market Value (US$ Mn), by Biological Valves, 2020-2034
Figure 24: Global Heart Valve Devices Market Value Share Analysis, by Biological Valves, 2023 and 2034
Figure 25: Global Heart Valve Devices Market Value (US$ Mn), by Mechanical Valves, 2020-2034
Figure 26: Global Heart Valve Devices Market Value Share Analysis, by Mechanical Valves, 2023 and 2034
Figure 27: Global Heart Valve Devices Market Value (US$ Mn) Share Analysis, by Age Group, 2023 and 2034
Figure 28: Global Heart Valve Devices Market Share Analysis, by Age Group, 2023
Figure 29: Global Heart Valve Devices Market Share Analysis, by Age Group, 2034
Figure 30: Global Heart Valve Devices Market Attractiveness Analysis, by Age Group, 2024-2034
Figure 31: Global Heart Valve Devices Market Value (US$ Mn), by Pediatric Patients, 2020-2034
Figure 32: Global Heart Valve Devices Market Value Share Analysis, by Pediatric Patients, 2023 and 2034
Figure 33: Global Heart Valve Devices Market Value (US$ Mn), by Adults, 2020-2034
Figure 34: Global Heart Valve Devices Market Value Share Analysis, by Adults, 2023 and 2034
Figure 35: Global Heart Valve Devices Market Value (US$ Mn), by Geriatric Patients, 2020-2034
Figure 36: Global Heart Valve Devices Market Value Share Analysis, by Geriatric Patients, 2023 and 2034
Figure 37: Global Heart Valve Devices Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 38: Global Heart Valve Devices Market Share Analysis, by End-user, 2023
Figure 39: Global Heart Valve Devices Market Share Analysis, by End-user, 2034
Figure 40: Global Heart Valve Devices Market Attractiveness Analysis, by End-user, 2024-2034
Figure 41: Global Heart Valve Devices Market Value (US$ Mn), by Hospitals, 2020-2034
Figure 42: Global Heart Valve Devices Market Value Share Analysis, by Hospitals, 2023 and 2034
Figure 43: Global Heart Valve Devices Market Value (US$ Mn), by Ambulatory Surgical Centers, 2020-2034
Figure 44: Global Heart Valve Devices Market Value Share Analysis, by Ambulatory Surgical Centers, 2023 and 2034
Figure 45: Global Heart Valve Devices Market Value (US$ Mn), by Others, 2020-2034
Figure 46: Global Heart Valve Devices Market Value Share Analysis, by Others, 2023 and 2034
Figure 47: Global Heart Valve Devices Market Value Share Analysis, by Region, 2023 and 2034
Figure 48: Global Heart Valve Devices Market Share Analysis, by Region, 2023
Figure 49: Global Heart Valve Devices Market Share Analysis, by Region, 2034
Figure 50: Global Heart Valve Devices Market Attractiveness Analysis, by Region, 2023-2034
Figure 51: North America Heart Valve Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 52: North America Heart Valve Devices Market Value Share Analysis, by Country, 2023 and 2034
Figure 53: North America Heart Valve Devices Market Attractiveness Analysis, by Country, 2024-2034
Figure 54: North America Heart Valve Devices Market Value (US$ Mn) Share Analysis, by Type of Heart Valve, 2023 and 2034
Figure 55: North America Heart Valve Devices Market Attractiveness Analysis, by Type of Heart Valve, 2024-2034
Figure 56: North America Heart Valve Devices Market Value (US$ Mn) Share Analysis, by Material, 2023 and 2034
Figure 57: North America Heart Valve Devices Market Attractiveness Analysis, by Material, 2024-2034
Figure 58: North America Heart Valve Devices Market Value (US$ Mn) Share Analysis, by Age Group, 2023 and 2034
Figure 59: North America Heart Valve Devices Market Attractiveness Analysis, by Age Group, 2024-2034
Figure 60: North America Heart Valve Devices Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 61: North America Heart Valve Devices Market Attractiveness Analysis, by End-user, 2024-2034
Figure 62: Europe Heart Valve Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 63: Europe Heart Valve Devices Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 64: Europe Heart Valve Devices Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 65: Europe Heart Valve Devices Market Value (US$ Mn) Share Analysis, by Type of Heart Valve, 2023 and 2034
Figure 66: Europe Heart Valve Devices Market Attractiveness Analysis, by Type of Heart Valve, 2024-2034
Figure 67: Europe Heart Valve Devices Market Value (US$ Mn) Share Analysis, by Material, 2023 and 2034
Figure 68: Europe Heart Valve Devices Market Attractiveness Analysis, by Material, 2024-2034
Figure 69: Europe Heart Valve Devices Market Value (US$ Mn) Share Analysis, by Age Group, 2023 and 2034
Figure 70: Europe Heart Valve Devices Market Attractiveness Analysis, by Age Group, 2024-2034
Figure 71: Europe Heart Valve Devices Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 72: Europe Heart Valve Devices Market Attractiveness Analysis, by End-user, 2024-2034
Figure 73: Asia Pacific Heart Valve Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 74: Asia Pacific Heart Valve Devices Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 75: Asia Pacific Heart Valve Devices Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 76: Asia Pacific Heart Valve Devices Market Value (US$ Mn) Share Analysis, by Type of Heart Valve, 2023 and 2034
Figure 77: Asia Pacific Heart Valve Devices Market Attractiveness Analysis, by Type of Heart Valve, 2024-2034
Figure 78: Asia Pacific Heart Valve Devices Market Value (US$ Mn) Share Analysis, by Material, 2023 and 2034
Figure 79: Asia Pacific Heart Valve Devices Market Attractiveness Analysis, by Material, 2024-2034
Figure 80: Asia Pacific Heart Valve Devices Market Value (US$ Mn) Share Analysis, by Age Group, 2023 and 2034
Figure 81: Asia Pacific Heart Valve Devices Market Attractiveness Analysis, by Age Group, 2024-2034
Figure 82: Asia Pacific Heart Valve Devices Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 83: Asia Pacific Heart Valve Devices Market Attractiveness Analysis, by End-user, 2024-2034
Figure 84: Latin America Heart Valve Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 85: Latin America Heart Valve Devices Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 86: Latin America Heart Valve Devices Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 87: Latin America Heart Valve Devices Market Value (US$ Mn) Share Analysis, by Type of Heart Valve, 2023 and 2034
Figure 88: Latin America Heart Valve Devices Market Attractiveness Analysis, by Type of Heart Valve, 2024-2034
Figure 89: Latin America Heart Valve Devices Market Value (US$ Mn) Share Analysis, by Material, 2023 and 2034
Figure 90: Latin America Heart Valve Devices Market Attractiveness Analysis, by Material, 2024-2034
Figure 91: Latin America Heart Valve Devices Market Value (US$ Mn) Share Analysis, by Age Group, 2023 and 2034
Figure 92: Latin America Heart Valve Devices Market Attractiveness Analysis, by Age Group, 2024-2034
Figure 93: Latin America Heart Valve Devices Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 94: Latin America Heart Valve Devices Market Attractiveness Analysis, by End-user, 2024-2034
Figure 95: Middle East & Africa Heart Valve Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 96: Middle East & Africa Heart Valve Devices Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 97: Middle East & Africa Heart Valve Devices Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 98: Middle East & Africa Heart Valve Devices Market Value (US$ Mn) Share Analysis, by Type of Heart Valve, 2023 and 2034
Figure 99: Middle East & Africa Heart Valve Devices Market Attractiveness Analysis, by Type of Heart Valve, 2024-2034
Figure 100: Middle East & Africa Heart Valve Devices Market Value (US$ Mn) Share Analysis, by Material, 2023 and 2034
Figure 101: Middle East & Africa Heart Valve Devices Market Attractiveness Analysis, by Material, 2024-2034
Figure 102: Middle East & Africa Heart Valve Devices Market Value (US$ Mn) Share Analysis, by Age Group, 2023 and 2034
Figure 103: Middle East & Africa Heart Valve Devices Market Attractiveness Analysis, by Age Group, 2024-2034
Figure 104: Middle East & Africa Heart Valve Devices Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 105: Middle East & Africa Heart Valve Devices Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Heart Valve Devices Market
